187 related articles for article (PubMed ID: 23840885)
1. Variations of the UNC13D gene in patients with autoimmune lymphoproliferative syndrome.
Aricò M; Boggio E; Cetica V; Melensi M; Orilieri E; Clemente N; Cappellano G; Buttini S; Soluri MF; Comi C; Dufour C; Pende D; Dianzani I; Ellis SR; Pagliano S; Marcenaro S; Ramenghi U; Chiocchetti A; Dianzani U
PLoS One; 2013; 8(7):e68045. PubMed ID: 23840885
[TBL] [Abstract][Full Text] [Related]
2. Mutation of FAS, XIAP, and UNC13D genes in a patient with a complex lymphoproliferative phenotype.
Boggio E; Aricò M; Melensi M; Dianzani I; Ramenghi U; Dianzani U; Chiocchetti A
Pediatrics; 2013 Oct; 132(4):e1052-8. PubMed ID: 24043286
[TBL] [Abstract][Full Text] [Related]
3. Synergistic defects of novo FAS and homozygous UNC13D leading to autoimmune lymphoproliferative syndrome-like disease: A 10-year-old Chinese boy case report.
Gu H; Ma J; Chen Z; Wang J; Zhang R; Wu R
Gene; 2018 Sep; 672():45-49. PubMed ID: 29864493
[TBL] [Abstract][Full Text] [Related]
4. Variations of the perforin gene in patients with autoimmunity/lymphoproliferation and defective Fas function.
Clementi R; Chiocchetti A; Cappellano G; Cerutti E; Ferretti M; Orilieri E; Dianzani I; Ferrarini M; Bregni M; Danesino C; Bozzi V; Putti MC; Cerutti F; Cometa A; Locatelli F; Maccario R; Ramenghi U; Dianzani U
Blood; 2006 Nov; 108(9):3079-84. PubMed ID: 16720836
[TBL] [Abstract][Full Text] [Related]
5. IL-17 protects T cells from apoptosis and contributes to development of ALPS-like phenotypes.
Boggio E; Clemente N; Mondino A; Cappellano G; Orilieri E; Gigliotti CL; Toth E; Ramenghi U; Dianzani U; Chiocchetti A
Blood; 2014 Feb; 123(8):1178-86. PubMed ID: 24363402
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune lymphoproliferative syndrome due to somatic FAS mutation (ALPS-sFAS) combined with a germline caspase-10 (CASP10) variation.
Martínez-Feito A; Melero J; Mora-Díaz S; Rodríguez-Vigil C; Elduayen R; González-Granado LI; Pérez-Méndez D; Sánchez-Zapardiel E; Ruiz-García R; Menchén M; Díaz-Madroñero J; Paz-Artal E; Del Orbe-Barreto R; Riñón M; Allende LM
Immunobiology; 2016 Jan; 221(1):40-7. PubMed ID: 26323380
[TBL] [Abstract][Full Text] [Related]
7. The -346T polymorphism of the SH2D1A gene is a risk factor for development of autoimmunity/lymphoproliferation in males with defective Fas function.
Boggio E; Melensi M; Bocca S; Chiocchetti A; Comi C; Clemente N; Orilieri E; Soluri MF; D'Alfonso S; Mechelli R; Gentile G; Poggi A; Salvetti M; Ramenghi U; Dianzani U
Hum Immunol; 2012 May; 73(5):585-92. PubMed ID: 22425739
[TBL] [Abstract][Full Text] [Related]
8. High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation.
Chiocchetti A; Indelicato M; Bensi T; Mesturini R; Giordano M; Sametti S; Castelli L; Bottarel F; Mazzarino MC; Garbarini L; Giacopelli F; Valesini G; Santoro C; Dianzani I; Ramenghi U; Dianzani U
Blood; 2004 Feb; 103(4):1376-82. PubMed ID: 14592838
[TBL] [Abstract][Full Text] [Related]
9. Next Generation Sequencing for Detecting Somatic
López-Nevado M; Docampo-Cordeiro J; Ramos JT; Rodríguez-Pena R; Gil-López C; Sánchez-Ramón S; Gil-Herrera J; Díaz-Madroñero MJ; Delgado-Martín MA; Morales-Pérez P; Paz-Artal E; Magerus A; Rieux-Laucat F; Allende LM
Front Immunol; 2021; 12():656356. PubMed ID: 33995372
[TBL] [Abstract][Full Text] [Related]
10. Mutation spectrum in children with primary hemophagocytic lymphohistiocytosis: molecular and functional analyses of PRF1, UNC13D, STX11, and RAB27A.
Zur Stadt U; Beutel K; Kolberg S; Schneppenheim R; Kabisch H; Janka G; Hennies HC
Hum Mutat; 2006 Jan; 27(1):62-8. PubMed ID: 16278825
[TBL] [Abstract][Full Text] [Related]
11. Clinical, immunological, and genetic features in 780 patients with autoimmune lymphoproliferative syndrome (ALPS) and ALPS-like diseases: A systematic review.
Hafezi N; Zaki-Dizaji M; Nirouei M; Asadi G; Sharifinejad N; Jamee M; Erfan Rasouli S; Hamedifar H; Sabzevari A; Chavoshzadeh Z; Yazdani R; Abolhassani H; Aghamohammadi A; Azizi G
Pediatr Allergy Immunol; 2021 Oct; 32(7):1519-1532. PubMed ID: 33963613
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune lymphoproliferative syndrome misdiagnosed as hemophagocytic lymphohistiocytosis.
Rudman Spergel A; Walkovich K; Price S; Niemela JE; Wright D; Fleisher TA; Rao VK
Pediatrics; 2013 Nov; 132(5):e1440-4. PubMed ID: 24101757
[TBL] [Abstract][Full Text] [Related]
13. Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations.
Price S; Shaw PA; Seitz A; Joshi G; Davis J; Niemela JE; Perkins K; Hornung RL; Folio L; Rosenberg PS; Puck JM; Hsu AP; Lo B; Pittaluga S; Jaffe ES; Fleisher TA; Rao VK; Lenardo MJ
Blood; 2014 Mar; 123(13):1989-99. PubMed ID: 24398331
[TBL] [Abstract][Full Text] [Related]
14. Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndrome.
Zhu S; Hsu AP; Vacek MM; Zheng L; Schäffer AA; Dale JK; Davis J; Fischer RE; Straus SE; Boruchov D; Saulsbury FT; Lenardo MJ; Puck JM
Hum Genet; 2006 Apr; 119(3):284-94. PubMed ID: 16446975
[TBL] [Abstract][Full Text] [Related]
15. The contribution of rare copy number variants in FAS toward pathogenesis of autoimmune lymphoproliferative syndrome.
Jevtich K; Price S; Similuk M; Kulm E; Yan J; Setzer M; Jamal L; Franco LM; Ghosh R; Walkiewicz M; Rao VK
Blood Adv; 2022 Jul; 6(13):3974-3978. PubMed ID: 35476126
[TBL] [Abstract][Full Text] [Related]
16. Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS).
Lisco A; Wong CS; Price S; Ye P; Niemela J; Anderson M; Richards E; Manion M; Mystakelis H; Similuk M; Lo B; Stoddard J; Rosenzweig S; Vanpouille C; Rupert A; Maric I; Perez-Diez A; Parenti D; Burbelo PD; Rao VK; Sereti I
Front Immunol; 2019; 10():1193. PubMed ID: 31191551
[TBL] [Abstract][Full Text] [Related]
17. Novel insights into FAS defects underlying autoimmune lymphoproliferative syndrome revealed by studies in consanguineous patients.
Ben-Mustapha I; Agrebi N; Barbouche MR
J Leukoc Biol; 2018 Mar; 103(3):501-508. PubMed ID: 29345341
[TBL] [Abstract][Full Text] [Related]
18. FAS-mediated apoptosis impairment in patients with ALPS/ALPS-like phenotype carrying variants on CASP10 gene.
Miano M; Cappelli E; Pezzulla A; Venè R; Grossi A; Terranova P; Palmisani E; Maggiore R; Guardo D; Lanza T; Calvillo M; Micalizzi C; Pierri F; Vernarecci C; Beccaria A; Corsolini F; Lanciotti M; Russo G; Ceccherini I; Dufour C; Fioredda F
Br J Haematol; 2019 Nov; 187(4):502-508. PubMed ID: 31309545
[TBL] [Abstract][Full Text] [Related]
19. Decreased activation-induced cell death by EBV-transformed B-cells from a patient with autoimmune lymphoproliferative syndrome caused by a novel FASLG mutation.
Ruiz-García R; Mora S; Lozano-Sánchez G; Martínez-Lostao L; Paz-Artal E; Ruiz-Contreras J; Anel A; González-Granado LI; Moreno-Pérez D; Allende LM
Pediatr Res; 2015 Dec; 78(6):603-8. PubMed ID: 26334989
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune lymphoproliferative syndrome caused by a homozygous null FAS ligand (FASLG) mutation.
Magerus-Chatinet A; Stolzenberg MC; Lanzarotti N; Neven B; Daussy C; Picard C; Neveux N; Desai M; Rao M; Ghosh K; Madkaikar M; Fischer A; Rieux-Laucat F
J Allergy Clin Immunol; 2013 Feb; 131(2):486-90. PubMed ID: 22857792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
